Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
OHSU Knight Cancer Institute
First Affiliated Hospital of Zhejiang University
NYU Langone Health